$4.26
6.17% yesterday
Nasdaq, Oct 30, 09:17 pm CET
ISIN
US39959A2050
Symbol
UPXI

Upexi Stock price

$4.26
-1.51 26.17% 1M
-6.68 61.06% 6M
+0.75 21.36% YTD
-3.71 46.55% 1Y
-101.74 95.98% 3Y
-107.74 96.20% 5Y
-107.74 96.20% 10Y
-107.74 96.20% 20Y
Nasdaq, Closing price Thu, Oct 30 2025
-0.28 6.17%
ISIN
US39959A2050
Symbol
UPXI

Key metrics

Basic
Market capitalization
$250.9m
Enterprise Value
$273.8m
Net debt
$23.0m
Cash
$3.0m
Shares outstanding
38.3m
Valuation (TTM | estimate)
P/E
negative | 139.2
P/S
15.9 | 6.5
EV/Sales
17.3 | 7.0
EV/FCF
negative
P/B
2.8
Financial Health
Equity Ratio
72.8%
Return on Equity
-15.2%
ROCE
-14.1%
ROIC
-10.8%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$15.8m | $38.9m
EBITDA
$-12.1m | -
EBIT
$-12.9m | $1.5m
Net Income
$-13.7m | $1.2m
Free Cash Flow
$-113.7m
Growth (TTM | estimate)
Revenue
-70.4% | 145.8%
EBITDA
-40.8% | -
EBIT
11.4% | 111.9%
Net Income
45.3% | 108.6%
Free Cash Flow
-10,940.8%
Margin (TTM | estimate)
Gross
68.7%
EBITDA
-76.6% | -
EBIT
-81.4%
Net
-86.6% | 3.0%
Free Cash Flow
-719.2%
More
EPS
$-0.5
FCF per Share
$-3.0
Short interest
15.8%
Employees
64
Rev per Employee
$250.0k
Show more

Is Upexi a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,029 stocks worldwide.

Upexi Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Upexi forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Upexi forecast:

Buy
88%
Hold
13%

Financial data from Upexi

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
16 16
70% 70%
100%
- Direct Costs 4.94 4.94
84% 84%
31%
11 11
50% 50%
69%
- Selling and Administrative Expenses 23 23
26% 26%
145%
- Research and Development Expense - -
-
-
-12 -12
41% 41%
-77%
- Depreciation and Amortization 0.76 0.76
87% 87%
5%
EBIT (Operating Income) EBIT -13 -13
11% 11%
-81%
Net Profit -14 -14
45% 45%
-87%

In millions USD.

Don't miss a Thing! We will send you all news about Upexi directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Upexi Stock News

Neutral
GlobeNewsWire
8 days ago
TAMPA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, today announced the addition of Jon Najarian (Twitter: @jonnajarian) to the Upexi Advisory Committee, joining Arthur Hayes and S◎L Big Brain as founding Upexi Advisory Co...
Neutral
GlobeNewsWire
about one month ago
SOL Treasury Increased 174% and Net Asset Value Increased 281% since the fiscal year ended June 30, 2025 SOL Treasury Increased 174% and Net Asset Value Increased 281% since the fiscal year ended June 30, 2025
Neutral
PRNewsWire
about 2 months ago
NEW YORK , Sept. 11, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Upexi, Inc. (NASDAQ: UPXI) on behalf of the company's shareholders.
More Upexi News

Company Profile

Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. Its brands include LuckyTail, Prax, Cure Mushrooms, Moonwlkr, and Gumi Labs. The company was founded on September 5, 2018 and is headquartered in Tampa, FL.

Head office United States
CEO Allan Marshall
Employees 64
Website upexi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today